Is AVUV a Buy? What to Consider in 2026

AVUV is the Avantis U.S. Small Cap Value ETF, an actively managed fund run by Avantis Investors (a unit of American Century Investments) that launched in September 2019. Rather than tracking a fixed index, AVUV uses a systematic, rules-based process to hold a broad basket of roughly 700 to 800 small-cap U.S. stocks, then tilts the portfolio toward companies with low price-to-book valuations and high profitability. The result is a deeper, more deliberate value-and-profitability tilt than a typical passive small-cap value index fund, while still keeping costs relatively low at a 0.25% expense ratio. The fund has grown rapidly to roughly $28 billion in assets and is widely used by factor-focused and evidence-based investors. Holdings span hundreds of small companies across financials, industrials, energy, and consumer cyclical sectors, with no single position dominating the portfolio.

Largest holdings (approximate as of early 2026; verify on Avantis Investors (American Century Investments)'s fund page):

AVUV is an actively managed, systematic small-cap value ETF from Avantis (American Century) that screens for cheap valuations combined with high profitability, and it has become one of the most popular factor funds in the category. Because Avantis tilts deliberately toward the smallest and most value-oriented names rather than tracking an index, AVUV is generally more concentrated in the value and profitability factors than a broad benchmark fund like the iShares Russell 2000 Value ETF (IWN). Compared with the Vanguard Small-Cap Value ETF (VBR), which is passive and includes larger, less deeply discounted names, AVUV leans into smaller, deeper-value stocks. It is most directly comparable to the DFA Dimensional U.S. Small Cap Value ETF (DFSV), which uses a similar profitability-screened, actively managed approach.

In its favour: it gives you Actively managed (no index); systematic U.S. small-cap value tilt exposure in one ticker at a 0.25% expense ratio, which is simple to hold and cheap to own.

• Cost vs alternatives: 0.25% is the fee; compare it to funds tracking a similar index.
• Concentration: check how much of AVUV sits in its largest holdings (VSAT, SM, MATX).
• Overlap: if you already own a broad-market fund, you may already hold much of this.
• Tracking scope: AVUV only gives you Actively managed (no index); systematic U.S. small-cap value tilt; it will not capture what sits outside that index.

The useful question is rarely “will AVUV go up?” It is “does this exposure fit my plan, at a cost I am happy with, without doubling up on what I already own?” Walnut connects your real brokerage so you can see exactly how AVUV would overlap with your current holdings, analyze it by chatting through Claude or ChatGPT, and place any trade yourself. You stay in control.

The bottom line: AVUV is a low-cost core building block for Actively managed (no index); systematic U.S. small-cap value tilt exposure, not a tactical bet on a single name. If you want Actively managed (no index); systematic U.S. small-cap value tilt exposure and the 0.25% fee is competitive for you, it does its job well. If you already own that exposure through another fund, adding it mostly doubles a fee without adding diversification. Decide from your goal and your existing holdings, not from where the market sat last week. Walnut is not an investment adviser.